Risk factors for level V metastasis in patients with N1b papillary thyroid cancer

被引:0
|
作者
Kang, Jin Gu [1 ]
Choi, Jung Eun [1 ]
Kang, Su Hwan [1 ]
机构
[1] Yeungnam Univ, Dept Surg, Coll Med, 170 Hyunchoong ro, Daegu 42415, South Korea
关键词
Lymph node metastasis; Neck dissection; Thyroid cancer; LYMPH-NODE METASTASIS; LATERAL NECK; PREDICTIVE FACTORS; CARCINOMA; DISSECTION; PATTERN; METAANALYSIS; EXTENT;
D O I
10.1186/s12957-022-02782-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, and its incidence has increased. Lateral lymph node metastasis (LLNM) implies a worse prognosis than central lymph node metastasis, with a higher recurrence rate and decreased disease-free survival. The 2015 American Thyroid Association guidelines recommend compartmental node dissection in patients with LLNM to reduce the risk of recurrence and mortality. The purpose of this study was to identify the risk factors for level V lymph node (LN) metastasis in patients with N1b papillary thyroid cancer (PTC). Methods A total of 110 consecutive patients who underwent total thyroidectomy with lateral neck dissection for PTC between April 2016 and April 2022 were retrospectively enrolled. Based on level V metastasis, 94 patients were divided into two groups, and their clinicopathological characteristics were compared. Univariable analysis were used to assess the factors associated with level V metastasis. Spearman correlation analysis were used to assess the correlation between tumors and LN. The receiver operating characteristic (ROC) curve was used to determine the optimal cutoff value for the number of metastatic LNs at each level for level V metastasis. Results The number of metastatic LNs and lymph node ratio (LNR) in level II were significantly associated with level V metastasis (P = 0.011 and 0.001, respectively). The number of metastatic LNs in level II and those in the total number of levels correlated with the number of metastatic LNs in level V (rho = 0.331, 0.325, and P = 0.001, 0.001, respectively). The cutoff value for the number of metastatic LNs in level II was defined as 2.5 (area under the curve = 0.757, sensitivity = 50%, specificity = 82.5%, 95% confidence interval [CI] 0.626-0.889, P = 0.002). Simultaneous 3-level metastasis (level II, III, and IV) and 3-level with >= 2.5 metastatic LNs in level II were significantly associated with level V metastasis (P = 0.003 and 0.002). Conclusions The number of metastatic LNs and LNR in level II, simultaneous 3-level metastasis (level II, III, and IV), and 3-level with >= 2.5 metastatic LNs in level II were significantly associated with level V metastasis. (P = 0.011, 0.001, 0.003, and 0.002, respectively). In the future, larger-scale multi-institutional studies were needed to find out predictors for level V metastasis.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
    Jin, Meihua
    Ahn, Jonghwa
    Lee, Yu-Mi
    Sung, Tae-Yon
    Kim, Won Gu
    Kim, Tae Yong
    Ryu, Jin-Sook
    Kim, Won
    Shong, Young Kee
    Jeon, Min Ji
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (03) : 602 - 609
  • [32] Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer
    Wang, Laura Y.
    Palmer, Frank L.
    Nixon, Iain J.
    Tuttle, R. Michael
    Shah, Jatin P.
    Patel, Snehal G.
    Shaha, Ashok R.
    Ganly, Ian
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (11) : 3530 - 3536
  • [33] Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome
    Sapuppo, G.
    Palermo, F.
    Russo, M.
    Tavarelli, M.
    Masucci, R.
    Squatrito, S.
    Vigneri, R.
    Pellegriti, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (12): : 1355 - 1363
  • [34] Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome
    G. Sapuppo
    F. Palermo
    M. Russo
    M. Tavarelli
    R. Masucci
    S. Squatrito
    R. Vigneri
    G. Pellegriti
    Journal of Endocrinological Investigation, 2017, 40 : 1355 - 1363
  • [35] UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY
    Liu, Yan-Qing
    Li, Hui
    Liu, Jie-Rui
    Lin, Yan-Song
    ENDOCRINE PRACTICE, 2019, 25 (12) : 1286 - 1294
  • [36] Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma
    Wu, Xin
    Li, Binglu
    Zheng, Chaoji
    He, Xiaodong
    CANCER MEDICINE, 2023, 12 (06): : 7560 - 7566
  • [37] Level IIb neck dissection guided by fine-needle aspiration for N1b papillary thyroid carcinoma
    Song, Yuntao
    Xu, Guohui
    Bai, Yanhua
    Wang, Tianxiao
    Fei, Kuangyu
    Zhang, Bin
    SURGICAL ONCOLOGY-OXFORD, 2022, 40
  • [38] ASO Author Reflections: A Promising Approach of Endoscopic Surgery for Lateral Neck Dissection in Patients with N1b Papillary Thyroid Cancer
    Zheng, Guibin
    Zheng, Haitao
    Song, Xicheng
    ANNALS OF SURGICAL ONCOLOGY, 2023, 31 (3) : 1521 - 1521
  • [39] ASO Author Reflections: A Promising Approach of Endoscopic Surgery for Lateral Neck Dissection in Patients with N1b Papillary Thyroid Cancer
    Guibin Zheng
    Haitao Zheng
    Xicheng Song
    Annals of Surgical Oncology, 2024, 31 : 1521 - 1521
  • [40] Identifying risk factors for metastasis to the level VII lymph node in papillary thyroid carcinoma patients
    Jian Chen
    Deguang Zhang
    Liang Fang
    Gaofei He
    Li Gao
    BMC Surgery, 20